BDBM708518 3-(5-(3-(2-((3r,5r,7r)- adamantan-1-yl)ethyl)-3,6- diazabicyclo[3.1.1]heptan- 6-yl)-2-methyl-4- oxoquinazolin- 3(4H)-yl)piperidine-2,6-dione::US20240425475, Compound GT-04231

SMILES Cc1nc2cccc(N3C4CC3CN(CCC35CC6CC(CC(C6)C3)C5)C4)c2c(=O)n1C1CCC(=O)NC1=O

InChI Key InChIKey=ZHMUZKOMMKHRFN-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 708518   

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM708518(3-(5-(3-(2-((3r,5r,7r)- adamantan-1-yl)ethyl)-3,6-...)
Affinity DataIC50: 3.24E+3nMAssay Description:1. According to the instructions of the CEREBLON BINDING kits, the compounds to be tested of the present invention and lenalidomide were serially dil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent